BioLineRx reports "positive" results from GENESIS Phase 3 trial of motixafortide
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers reports "positive" results from Phase 3 CheckMate -648 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ampio reports "preliminary positive results" in AP-014 Phase I trial of Ampion
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
KalVista reports "positive" results from Phase 2 trial of KVD900
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Regeneron reports "positive" results from Phase 3 trial evaluating REGEN-COV
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
DBV Technologies reports "positive" topline results from Phase III trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
 -- Reported Positive Topline Results from Pivotal Phase 3 URIROX-1 Trial.....»»
miRagen Reports Third Quarter 2019 Results and Provides Corporate Update
Announced positive data from two Phase 1 clinical trials of MRG-110 Remain on track to announce interim top-line data from its Phase 2 clinical trial of remlarsen in keloids by year end Implemented restructuring to focus resour.....»»
Krystal Biotech Reports Second Quarter 2019 Financial and Operating Results
FDA grants RMAT designation for KB103 to treat dystrophic epidermolysis bullosa (DEB) Announced positive results from Phase 2 trial ("GEM-2") of KB103 Submitted an IND application .....»»
Biohaven reports "positive" results from Phase 3 rimegepant clinical trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aclaris Therapeutics reports "positive" results from Phase 2 trial of ATI-502
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol-Myers Reports Positive Data in NSCLC Trial on Opdivo
Bristol-Myers Squibb Company (BMY) announced positive results from the phase III trial, CheckMate -0.....»»
Bristol-Myers reports "positive" results from Phase 3 CheckMate -078 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
MediciNova reports "positive" results from Phase 2 trial of MN-001
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie Posts Positive Data on Elagolix for Uterine Fibroids
AbbVie (ABBV) reports positive top-line results from a phase III extension trial on its investigational candidate Elagolix for .....»»
ObsEva reports additional "positive" Phase 3 results of IMPLANT 2 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Concert Pharmaceuticals reports "positive" CTP-543 results in Phase 2a trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alkermes reports positive results in trial of schizophrenia treatment that reduces weight gain
Alkermes Plc announced positive results Thursday for a trial of its ALKS 3832 treatment for schizophrenia. The Phase 3 tr.....»»
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile. read more.....»»
Exelixis reports Phase 1b results from Cohort 6 of COSMIC-021 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Incyte reports positive Phase 3 results for Ruxolitinib cream in vitiligo
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»